{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:04:13Z","timestamp":1745640253307,"version":"3.40.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06213-4","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T02:21:17Z","timestamp":1742350877000},"page":"1931-1947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients"],"prefix":"10.1007","volume":"104","author":[{"given":"Dongdi","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"17","key":"6213_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS (2018) Aplastic Anemia. N Engl J Med 379(17):1643\u20131656. https:\/\/doi.org\/10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"issue":"11","key":"6213_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","volume":"129","author":"A Bacigalupo","year":"2017","unstructured":"Bacigalupo A (2017) How I treat acquired aplastic anemia. Blood 129(11):1428\u20131436. https:\/\/doi.org\/10.1182\/blood-2016-08-693481","journal-title":"Blood"},{"issue":"1","key":"6213_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11684-017-0595-7","volume":"13","author":"M Lv","year":"2019","unstructured":"Lv M, Chang Y, Huang X (2019) Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Frontiers of medicine 13(1):45\u201356. https:\/\/doi.org\/10.1007\/s11684-017-0595-7","journal-title":"Frontiers of medicine"},{"issue":"1","key":"6213_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, Liu QF, Wang JM, Wang X, Jiang M, Zhang X, Wu DP, Huang XJ (2017) Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10(1):25","journal-title":"J Hematol Oncol"},{"key":"6213_CR5","doi-asserted-by":"crossref","unstructured":"Zhang Y, Huo J, Liu L, Shen Y, Chen J, Zhang T, Chen X, Pang A, Yang D, Zhang R, Ma Q, Zhai W, He Y, Wei J, Jiang E, Han M, Zheng Y, Feng S (2022) Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia. Front Immunol 13:837335","DOI":"10.3389\/fimmu.2022.837335"},{"key":"6213_CR6","doi-asserted-by":"crossref","unstructured":"Iftikhar R, Chaudhry QUN, Anwer F, Neupane K, Rafae A, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Khattak TA, Shamshad GU, Rehman J, Farhan M, Khan M, Ansar I, Ashraf R, Marsh J, Satti TM, Ahmed P (2021) Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies. Blood reviews 47 :100772","DOI":"10.1016\/j.blre.2020.100772"},{"issue":"12","key":"6213_CR7","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","volume":"107","author":"ZL Xu","year":"2022","unstructured":"Xu ZL, Xu LP, Wu DP, Wang SQ, Zhang X, Xi R, Gao SJ, Xia LH, Yang JM, Jiang M, Wang X, Liu QF, Chen J, Zhou M, Huang XJ (2022) Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study. Haematologica 107(12):2918\u20132927. https:\/\/doi.org\/10.3324\/haematol.2022.280758","journal-title":"Haematologica"},{"issue":"1","key":"6213_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, Lai YR, Liu DH, Liu QF, Liu T, Ren HY, Song YP, Sun ZM, Tang XW, Wang JM, Wu DP, Xu LP, Zhang X, Zhou DB, Huang XJ (2021) The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14(1):145. https:\/\/doi.org\/10.1186\/s13045-021-01159-2","journal-title":"J Hematol Oncol"},{"issue":"12","key":"6213_CR9","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41409-021-01431-6","volume":"56","author":"LP Xu","year":"2021","unstructured":"Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, Zhang X, Song YP, Song XM, Hu JD, Huang H, Lai YR, Wan DM, Chen J, Li CF, Xia LH, Wang JB, Liu DH, Huang XJ (2021) Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant 56(12):2940\u20132947. https:\/\/doi.org\/10.1038\/s41409-021-01431-6","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"6213_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1515\/cclm-2013-0168","volume":"51","author":"M Franchini","year":"2013","unstructured":"Franchini M, Liumbruno GM (2013) ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 51(8):1545\u20131553. https:\/\/doi.org\/10.1515\/cclm-2013-0168","journal-title":"Clin Chem Lab Med"},{"key":"6213_CR11","doi-asserted-by":"crossref","unstructured":"Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot Jr CC, Wright MWJNRG (2004) Gene map of the extended human MHC. 5 (12):889\u2013899","DOI":"10.1038\/nrg1489"},{"issue":"1","key":"6213_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2012.10.001","volume":"27","author":"EW Petersdorf","year":"2013","unstructured":"Petersdorf EW (2013) Genetics of graft-versus-host disease: the major histocompatibility complex. Blood Rev 27(1):1\u201312. https:\/\/doi.org\/10.1016\/j.blre.2012.10.001","journal-title":"Blood Rev"},{"issue":"30","key":"6213_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201327119","volume":"119","author":"NC Stenseth","year":"2022","unstructured":"Stenseth NC, Andersson L, Hoekstra HE (2022) Gregor Johann Mendel and the development of modern evolutionary biology. Proc Natl Acad Sci U S A 119(30). https:\/\/doi.org\/10.1073\/pnas.2201327119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"6213_CR14","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3324\/haematol.12933","volume":"93","author":"F Kimura","year":"2008","unstructured":"Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K (2008) Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 93(11):1686\u20131693. https:\/\/doi.org\/10.3324\/haematol.12933","journal-title":"Haematologica"},{"issue":"9","key":"6213_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/bmt.2011.135","volume":"46","author":"SD Rowley","year":"2011","unstructured":"Rowley SD, Donato ML, Bhattacharyya P (2011) Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 46(9):1167\u20131185. https:\/\/doi.org\/10.1038\/bmt.2011.135","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"6213_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood.V50.2.185.185","volume":"50","author":"RP Gale","year":"1977","unstructured":"Gale RP, Feig S, Ho W, Falk P, Rippee C, Sparkes R (1977) ABO blood group system and bone marrow transplantation. Blood 50(2):185\u2013194","journal-title":"Blood"},{"issue":"1","key":"6213_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2141.1980.tb01184.x","volume":"44","author":"C Hershko","year":"1980","unstructured":"Hershko C, Gale RP, Ho W, Fitchen J (1980) ABH antigens and bone marrow transplantation. Brit j haematol 44(1):65\u201373","journal-title":"Brit j haematol"},{"issue":"6","key":"6213_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1182\/blood.v98.6.1687","volume":"98","author":"CD Bolan","year":"2001","unstructured":"Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98(6):1687\u20131694. https:\/\/doi.org\/10.1182\/blood.v98.6.1687","journal-title":"Blood"},{"issue":"10","key":"6213_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/sj.bmt.1704264","volume":"32","author":"W Rabitsch","year":"2003","unstructured":"Rabitsch W, Kn\u00f6bl P, Prinz E, Keil F, Greinix H, Kalhs P, Worel N, Jansen M, H\u00f6rl WH, Derfler K (2003) Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant 32(10):1015\u20131019. https:\/\/doi.org\/10.1038\/sj.bmt.1704264","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"6213_CR20","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2018-10-833988","volume":"133","author":"R Goel","year":"2019","unstructured":"Goel R, Tobian AAR, Shaz BH (2019) Noninfectious transfusion-associated adverse events and their mitigation strategies. Blood 133(17):1831\u20131839. https:\/\/doi.org\/10.1182\/blood-2018-10-833988","journal-title":"Blood"},{"issue":"6","key":"6213_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","volume":"102","author":"J Canaani","year":"2017","unstructured":"Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, Tischer J, Koc Y, Bruno B, G\u00fclbas Z, Blaise D, Maertens J, Ehninger G, Mohty M, Nagler A (2017) Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT. Haematologica 102(6):1066\u20131074. https:\/\/doi.org\/10.3324\/haematol.2016.160804","journal-title":"Haematologica"},{"issue":"5","key":"6213_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1537-2995.2000.40050543.x","volume":"40","author":"N Worel","year":"2000","unstructured":"Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Kn\u00f6bl P, Reiter E, Derfler K, Fischer G, Hinterberger W, H\u00f6cker P, Kalhs P (2000) Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 40(5):543\u2013550. https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40050543.x","journal-title":"Transfusion"},{"issue":"1671\u20132587","key":"6213_CR23","doi-asserted-by":"publisher","first-page":"0586","DOI":"10.3969\/j.issn.1671-2587.2023.05.002","volume":"05","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Wei Y, Wang S, Zhang X, liu Q, Jiang E, Da W, Lan J, Ma X, Wang X, Wang Q, Fu D, Fu L, Bai H, Liu G, Liu H, et al (2023) Expert consensus on blood transfusion of allogeneic hematopoietic stem cell transplantation. Journal of Clinical Transfusion and Laboratory Medicine 05(1671\u20132587):0586\u20130594. https:\/\/doi.org\/10.3969\/j.issn.1671-2587.2023.05.002","journal-title":"Journal of Clinical Transfusion and Laboratory Medicine"},{"issue":"5","key":"6213_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bbmt.2018.01.003","volume":"24","author":"S Hosoba","year":"2018","unstructured":"Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, Giver CR (2018) Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24(5):973\u2013982. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"6213_CR25","doi-asserted-by":"publisher","first-page":"866.e861","DOI":"10.1016\/j.jtct.2021.07.001","volume":"27","author":"LK Gj\u00e6rde","year":"2021","unstructured":"Gj\u00e6rde LK, S\u00f8rensen ALT, von Stemann JH, Fischer-Nielsen A, Hansen MB, Sengel\u00f8v H, Ostrowski SR (2021) Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy 27(10):866.e861-866.e869. https:\/\/doi.org\/10.1016\/j.jtct.2021.07.001","journal-title":"Transplantation and cellular therapy"},{"key":"6213_CR26","doi-asserted-by":"publisher","unstructured":"Li G, Chen F, Wang N, Zhang M, Lu X, Chen H, Wang X (2022) A study of blood group conversion in patients with ABO incompatible hematopoietic stem cell transplantation-A decade survey. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis:103576. https:\/\/doi.org\/10.1016\/j.transci.2022.103576","DOI":"10.1016\/j.transci.2022.103576"},{"key":"6213_CR27","doi-asserted-by":"publisher","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, Patriquin CJ, Pham HP, Sanchez AP, Schneiderman J, Witt V, Zantek ND, Dunbar NM (2023) Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher 38 (2):77\u2013278. https:\/\/doi.org\/10.1002\/jca.22043","DOI":"10.1002\/jca.22043"},{"issue":"8580","key":"6213_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/s0140-6736(88)90388-1","volume":"1","author":"BM Camitta","year":"1988","unstructured":"Camitta BM (1988) Criteria for severe aplastic anaemia. Lancet 1(8580):303\u2013304. https:\/\/doi.org\/10.1016\/s0140-6736(88)90388-1","journal-title":"Lancet"},{"issue":"2","key":"6213_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187\u2013207. https:\/\/doi.org\/10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"issue":"1","key":"6213_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-022-01324-1","volume":"15","author":"L Liu","year":"2022","unstructured":"Liu L, Lei M, Fu R, Han B, Zhao X, Liu R, Zhang Y, Jiao W, Miao M, Zhang F, Zhang L, Wu D (2022) Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study. J Hematol Oncol 15(1):105","journal-title":"J Hematol Oncol"},{"key":"6213_CR31","unstructured":"Landsteiner KJZB (1900) Zur Kenntnis der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. 27:357\u2013362"},{"issue":"5","key":"6213_CR32","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3324\/haematol.2011.050096","volume":"97","author":"J Konopacki","year":"2012","unstructured":"Konopacki J, Porcher R, Robin M, Bieri S, Cayuela JM, Larghero J, Xhaard A, Andreoli AL, Dhedin N, Petropoulou A, Rodriguez-Otero P, Ribaud P, Moins-Teisserenc H, Carmagnat M, Toubert A, Chalandon Y, Socie G, Peffault de Latour R (2012) Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning. Haematologica-The Hematology Journal 97(5):710\u2013716","journal-title":"Haematologica-The Hematology Journal"},{"issue":"4","key":"6213_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bmt.2014.293","volume":"50","author":"H Nakasone","year":"2015","unstructured":"Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M (2015) Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone Marrow Transplant 50(4):559\u2013565. https:\/\/doi.org\/10.1038\/bmt.2014.293","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"6213_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","volume":"19","author":"GS Booth","year":"2013","unstructured":"Booth GS, Gehrie EA, Bolan CD, Savani BN (2013) Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol Blood Marrow Transplant 19(8):1152\u20131158. https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"6213_CR35","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1016\/j.transproceed.2009.06.189","volume":"41","author":"ZN Ozkurt","year":"2009","unstructured":"Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT (2009) Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation. Transpl Proc 41(9):3851\u20133858. https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.189","journal-title":"Transpl Proc"},{"issue":"3","key":"6213_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1365-2141.2001.02587.x","volume":"112","author":"CD Bolan","year":"2001","unstructured":"Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF (2001) Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 112(3):787\u2013795. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02587.x","journal-title":"Br J Haematol"},{"key":"6213_CR37","doi-asserted-by":"publisher","unstructured":"de La Rubia J, Arriaga F, Andreu R, Sanz G, Jim\u00e9nez C, Vicente A, Carpio N, Marty ML, Sanz MA (2001) Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 41 (1):106\u2013110. https:\/\/doi.org\/10.1046\/j.1537-2995.2001.41010106.x","DOI":"10.1046\/j.1537-2995.2001.41010106.x"},{"issue":"12","key":"6213_CR38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/sj.bmt.1703074","volume":"27","author":"PP Young","year":"2001","unstructured":"Young PP, Goodnough LT, Westervelt P, Diersio JF (2001) Immune hemolysis involving non-ABO\/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 27(12):1305\u20131310. https:\/\/doi.org\/10.1038\/sj.bmt.1703074","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"6213_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1537-2995.2003.00339.x","volume":"43","author":"A Xenocostas","year":"2003","unstructured":"Xenocostas A, Yee A, Wong CJ, Sutton DM, Lipton JH, Kiss TL, Messner HA (2003) RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival. Transfusion 43(3):373\u2013382. https:\/\/doi.org\/10.1046\/j.1537-2995.2003.00339.x","journal-title":"Transfusion"},{"issue":"17","key":"6213_CR40","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","volume":"133","author":"CA Tormey","year":"2019","unstructured":"Tormey CA, Hendrickson JE (2019) Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 133(17):1821\u20131830. https:\/\/doi.org\/10.1182\/blood-2018-08-833962","journal-title":"Blood"},{"key":"6213_CR41","doi-asserted-by":"publisher","unstructured":"Roubinian NH, Reese SE, Qiao H, Plimier C, Fang F, Page GP, Cable RG, Custer B, Gladwin MT, Goel R, Harris B, Hendrickson JE, Kanias T, Kleinman S, Mast AE, Sloan SR, Spencer BR, Spitalnik SL, Busch MP, Hod EA (2022) Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. JCI Insight 7 (1). https:\/\/doi.org\/10.1172\/jci.insight.152598","DOI":"10.1172\/jci.insight.152598"},{"issue":"12","key":"6213_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1631\/jzus.B2100491","volume":"22","author":"P Zhang","year":"2021","unstructured":"Zhang P, Xu D, Zhang X, Wu M, Yao X, Cui D, Xie J (2021) Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study. J Zhejiang Univ Sci B 22(12):1060\u20131064. https:\/\/doi.org\/10.1631\/jzus.B2100491","journal-title":"J Zhejiang Univ Sci B"},{"issue":"10","key":"6213_CR43","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","volume":"105","author":"SJ Slichter","year":"2005","unstructured":"Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105(10):4106\u20134114. https:\/\/doi.org\/10.1182\/blood-2003-08-2724","journal-title":"Blood"},{"issue":"10","key":"6213_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/trf.15961","volume":"60","author":"S Yuan","year":"2020","unstructured":"Yuan S, Yang D, Nakamura R, Zhuang L, Al Malki MM, Karanes C, Wang S (2020) Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant. Transfusion 60(10):2225\u20132242. https:\/\/doi.org\/10.1111\/trf.15961","journal-title":"Transfusion"},{"issue":"1","key":"6213_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.08073.x","volume":"149","author":"Z Wang","year":"2010","unstructured":"Wang Z, Sorror ML, Leisenring W, Schoch G, Maloney DG, Sandmaier BM, Storb R (2010) The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation. Br J Haematol 149(1):101\u2013110. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.08073.x","journal-title":"Br J Haematol"},{"issue":"18","key":"6213_CR46","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.4103\/0366-6999.240810","volume":"131","author":"LQ Cao","year":"2018","unstructured":"Cao LQ, Xu LP, Zhang XH, Wang Y, Liu YR, Liu KY, Huang XJ, Chang YJ (2018) Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34(+) and CD14(+) Cell Doses. Chin Med J 131(18):2185\u20132192. https:\/\/doi.org\/10.4103\/0366-6999.240810","journal-title":"Chin Med J"},{"issue":"6","key":"6213_CR47","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41409-020-0779-7","volume":"55","author":"YR Ma","year":"2020","unstructured":"Ma YR, Wang WJ, Cheng YF, Zhang YY, Mo XD, Han TT, Wang FR, Yan CH, Sun YQ, Chen YH, Wang JZ, Tang FF, Han W, Wang Y, Zhang XH, Huang XJ, Xu LP (2020) Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia. Bone marrow transpl 55(6):1068\u20131075","journal-title":"Bone marrow transpl"},{"issue":"7","key":"6213_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41409-023-01974-w","volume":"58","author":"ZL Xu","year":"2023","unstructured":"Xu ZL, Xu LP, Zhang YY, Cheng YF, Mo XD, Han TT, Wang FR, Yan CH, Sun YQ, Chen YH, Tang FF, Han W, Wang Y, Zhang XH, Liu KY, Huang XJ (2023) Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation. Bone Marrow Transplant 58(7):832\u2013834. https:\/\/doi.org\/10.1038\/s41409-023-01974-w","journal-title":"Bone Marrow Transplant"},{"issue":"10061","key":"6213_CR49","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/s0140-6736(15)01313-6","volume":"388","author":"M Delaney","year":"2016","unstructured":"Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A (2016) Transfusion reactions: prevention, diagnosis, and treatment. Lancet 388(10061):2825\u20132836. https:\/\/doi.org\/10.1016\/s0140-6736(15)01313-6","journal-title":"Lancet"},{"issue":"10","key":"6213_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/bmt.2016.140","volume":"51","author":"SE Lee","year":"2016","unstructured":"Lee SE, Yahng SA, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Lee S, Cho SG, Kim DW, Min WS, Lee JW (2016) Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia. Bone Marrow Transplant 51(10):1323\u20131329. https:\/\/doi.org\/10.1038\/bmt.2016.140","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"6213_CR51","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1038\/s41375-020-0933-7","volume":"34","author":"L Liu","year":"2020","unstructured":"Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D (2020) Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia. Leukemia 34(12):3359\u20133369","journal-title":"Leukemia"},{"issue":"11","key":"6213_CR52","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/bmt.2016.171","volume":"51","author":"SH Shin","year":"2016","unstructured":"Shin SH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, Lee JW (2016) Comparable outcomes between younger (\u2a7d40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning. Bone Marrow Transplant 51(11):1456\u20131463. https:\/\/doi.org\/10.1038\/bmt.2016.171","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"6213_CR53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ajh.25081","volume":"93","author":"A Bacigalupo","year":"2018","unstructured":"Bacigalupo A, Oneto R, Schrezenmeier H, Hochsmann B, Dufour C, Kojima S, Zhu X, Chen X, Issaragrisil S, Chuncharunee S, Jeong DC, Giammarco S, Van Lint MT, Zheng Y, Vallejo C (2018) First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001\u20132012. Am J Hematol 93(5):643\u2013648. https:\/\/doi.org\/10.1002\/ajh.25081","journal-title":"Am J Hematol"},{"issue":"20","key":"6213_CR54","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1182\/bloodadvances.2019000480","volume":"3","author":"VS Sheth","year":"2019","unstructured":"Sheth VS, Potter V, Gandhi SA, Kulasekararaj AG, de Lavallade H, Muus P, Pagliuca A, Rice CFM, Mehra V, Grimaldi F, Inam S, Barber LD, Mufti GJ, Marsh JC (2019) Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years. Blood Adv 3(20):3070\u20133079. https:\/\/doi.org\/10.1182\/bloodadvances.2019000480","journal-title":"Blood Adv"},{"issue":"4","key":"6213_CR55","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.intimp.2013.06.004","volume":"17","author":"C Page","year":"2013","unstructured":"Page C, Pitchford S (2013) Neutrophil and platelet complexes and their relevance to neutrophil recruitment and activation. Int Immunopharmacol 17(4):1176\u20131184. https:\/\/doi.org\/10.1016\/j.intimp.2013.06.004","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6213_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40779-020-00244-w","volume":"7","author":"JC Song","year":"2020","unstructured":"Song JC, Liu SY, Zhu F, Wen AQ, Ma LH, Li WQ, Wu J (2020) Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China. Mil Med Res 7(1):15. https:\/\/doi.org\/10.1186\/s40779-020-00244-w","journal-title":"Mil Med Res"},{"issue":"10","key":"6213_CR57","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","volume":"109","author":"P Armand","year":"2007","unstructured":"Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109(10):4586\u20134588. https:\/\/doi.org\/10.1182\/blood-2006-10-054924","journal-title":"Blood"},{"issue":"8","key":"6213_CR58","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1182\/blood-2007-10-118372","volume":"112","author":"JL Gajewski","year":"2008","unstructured":"Gajewski JL, Johnson VV, Sandler SG, Sayegh A, Klumpp TR (2008) A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 112(8):3036\u20133047. https:\/\/doi.org\/10.1182\/blood-2007-10-118372","journal-title":"Blood"},{"issue":"7","key":"6213_CR59","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/trf.16413","volume":"61","author":"S Subramanian","year":"2021","unstructured":"Subramanian S, Cohn C, DeFor T, Welbig J, Brunstein C, El Jurdi N, Weisdorf D (2021) Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type. Transfusion 61(7):2064\u20132074. https:\/\/doi.org\/10.1111\/trf.16413","journal-title":"Transfusion"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06213-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06213-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06213-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:21Z","timestamp":1745575821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06213-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6213"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06213-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}